This article was originally published in The Rose Sheet
Store openings contributed to a 14% rise in sales to $8.2 bil. for the fourth quarter (ended Aug. 31), while net earnings were up 11.9% to $277.1 mil., according to Walgreen. The firm opened 209 stores in the fourth quarter alone to total 4,227 locations. Store expansion in 2004 will be targeted to California, the Carolinas, Florida, Texas and Washington, and the retailer notes it is on track to reach 7,000 stores by 2010. Comparable store sales in Q4 were up 9.9%. Full year revenue was up 13.3% to $32.5 bil., with comparable store sales up 8.6%. Net earnings rose 15.4% to $1.18 bil. Walgreen notes it is budgeting more than $1 bil. in capital investments for the new fiscal year...
You may also be interested in...
Licensing agreements and bolt-on acquisitions to strengthen its R&D pipeline are still in Bayer’s sights as the COVID-19 pandemic and currency devaluations have led to the need for job cuts and substantial cost savings at the big pharma company.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-seven guidance documents have been posted on the tracker since its last update.
Despite a recent disappointment in a similar partnership with BioNTech, Genentech is pushing ahead with its neoantigen-targeting strategy.